BG104455A - Метод за получаване на производни от класа на таксоидите - Google Patents

Метод за получаване на производни от класа на таксоидите

Info

Publication number
BG104455A
BG104455A BG104455A BG10445500A BG104455A BG 104455 A BG104455 A BG 104455A BG 104455 A BG104455 A BG 104455A BG 10445500 A BG10445500 A BG 10445500A BG 104455 A BG104455 A BG 104455A
Authority
BG
Bulgaria
Prior art keywords
preparing derivatives
class
taxoid class
derivatives
taxoid
Prior art date
Application number
BG104455A
Other languages
English (en)
Other versions
BG64281B1 (bg
Inventor
Eric Didier
Gilles Oddon
Denis Pauze
Patrick Leon
Didier Riguet
Original Assignee
Rhone-Poulenc Rorer S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer S.A. filed Critical Rhone-Poulenc Rorer S.A.
Publication of BG104455A publication Critical patent/BG104455A/bg
Publication of BG64281B1 publication Critical patent/BG64281B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG104455A 1997-11-18 2000-05-18 М...'од за пол"-аван... на производни о' кла'а на 'ак'оиди'... BG64281B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714442A FR2771092B1 (fr) 1997-11-18 1997-11-18 Procede de preparation de derives de la classe des taxoides
PCT/FR1998/002432 WO1999025704A1 (fr) 1997-11-18 1998-11-16 Procede de preparation de derives de la classe des taxoides

Publications (2)

Publication Number Publication Date
BG104455A true BG104455A (bg) 2001-02-28
BG64281B1 BG64281B1 (bg) 2004-08-31

Family

ID=9513490

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104455A BG64281B1 (bg) 1997-11-18 2000-05-18 М...'од за пол"-аван... на производни о' кла'а на 'ак'оиди'...

Country Status (44)

Country Link
US (1) US5962705A (bg)
EP (1) EP1032565B1 (bg)
JP (1) JP4359386B2 (bg)
KR (1) KR100581656B1 (bg)
CN (1) CN100375744C (bg)
AP (1) AP1198A (bg)
AR (1) AR017639A1 (bg)
AT (1) ATE232855T1 (bg)
AU (1) AU755376B2 (bg)
BG (1) BG64281B1 (bg)
BR (1) BRPI9814658B8 (bg)
CA (1) CA2304833C (bg)
CO (1) CO4771105A1 (bg)
CZ (1) CZ292642B6 (bg)
DE (1) DE69811530T2 (bg)
DK (1) DK1032565T3 (bg)
DZ (1) DZ2653A1 (bg)
EA (1) EA002622B1 (bg)
EE (1) EE04277B1 (bg)
ES (1) ES2192795T3 (bg)
FR (1) FR2771092B1 (bg)
GE (1) GEP20022822B (bg)
HU (1) HU228188B1 (bg)
ID (1) ID24620A (bg)
IL (1) IL135512A (bg)
IN (1) IN191018B (bg)
IS (1) IS2272B (bg)
MA (1) MA24817A1 (bg)
MX (1) MXPA00002244A (bg)
MY (1) MY121031A (bg)
NO (1) NO325664B1 (bg)
NZ (1) NZ504125A (bg)
OA (1) OA11384A (bg)
PL (1) PL191240B1 (bg)
PT (1) PT1032565E (bg)
SI (1) SI1032565T1 (bg)
SK (1) SK283932B6 (bg)
TN (1) TNSN98207A1 (bg)
TR (1) TR200001415T2 (bg)
TW (1) TW518329B (bg)
UA (1) UA56275C2 (bg)
UY (1) UY25256A1 (bg)
WO (1) WO1999025704A1 (bg)
ZA (1) ZA9810511B (bg)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
US6346543B1 (en) 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
US6403634B1 (en) 1999-01-13 2002-06-11 Aventis Pharma S.A. Use of taxoid derivatives
FR2859996B1 (fr) 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
WO2010019233A1 (en) 2008-08-11 2010-02-18 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
ES2862340T3 (es) 2009-10-29 2021-10-07 Sanofi Mature Ip Nuevo uso antitumoral de cabazitaxel
US8791279B2 (en) 2010-12-13 2014-07-29 Yung Shin Pharm. Ind. Co., Ltd. Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US20130338216A1 (en) 2010-12-22 2013-12-19 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
EP2688877B1 (en) 2011-04-12 2017-03-08 Teva Pharmaceuticals International GmbH Solid state forms of cabazitaxel and processes for preparation thereof
TWI526437B (zh) 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN103012330A (zh) * 2011-09-23 2013-04-03 复旦大学 一种紫杉醇类抗癌药xrp6258的制备方法
CN103012329A (zh) * 2011-09-23 2013-04-03 复旦大学 一种制备紫杉醇类抗癌药Cabazitaxel XRP6258的方法
PL2760848T3 (pl) 2011-09-26 2019-07-31 Fresenius Kabi Oncology Limited Sposoby otrzymywania kabazytakselu powiązane z sililowaniem c(7)-oh i c(13)-oh lub z sililowaniem tylko c(7)-oh
CN102408397B (zh) * 2011-10-19 2014-08-20 上海贝美医药科技有限公司 紫杉烷类衍生物及其制备方法
CN102516281B (zh) * 2011-10-20 2015-02-04 江苏红豆杉生物科技股份有限公司 一种10-脱乙酰基巴卡丁iii及其衍生物甲氧基化的方法
WO2013072766A2 (en) 2011-10-31 2013-05-23 Scinopharm Taiwan, Ltd. Process for cabazitaxel and intermediates thereof
CN103159705B (zh) * 2011-12-12 2015-05-27 福建南方制药股份有限公司 卡巴他赛中间体的制备方法
CN103159704B (zh) * 2011-12-12 2015-06-10 上海佰霖国际贸易有限公司 卡巴他赛中间体及卡巴他赛中间体的制备方法
US9403785B2 (en) 2012-01-03 2016-08-02 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
CN102786502B (zh) * 2012-08-21 2014-05-14 江苏红豆杉生物科技有限公司 一种紫杉烷药物7,10-甲氧基多西他赛的合成方法
US9487496B2 (en) 2012-11-09 2016-11-08 Intas Pharmaceuticals Limited Process for the preparation of cabazitaxel and its intermediates
KR101407353B1 (ko) * 2012-12-04 2014-06-17 주식회사 삼양바이오팜 10-디아세틸바카틴 iii으로부터 카바지탁셀을 고수율로 제조하는 새로운 방법 및 이를 위한 신규 중간체
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103012331A (zh) * 2012-12-28 2013-04-03 北京科莱博医药开发有限责任公司 卡巴他赛及其中间体的制备方法
EP3008047B1 (en) * 2013-06-14 2019-01-09 Hetero Research Foundation Process for cabazitaxel
CN106632158B (zh) * 2013-08-28 2018-11-06 江苏恒瑞医药股份有限公司 7β,10β-二甲氧基-10-去乙酰基浆果赤霉素III的制备方法
CN103450117A (zh) * 2013-09-18 2013-12-18 江苏红豆杉药业有限公司 一种7,10-二甲氧基紫杉烷化合物的制备方法
KR101490738B1 (ko) 2013-10-15 2015-02-11 (주)한국해양기상기술 플랑크톤 검사장치
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN105121419B (zh) * 2013-12-24 2016-08-03 于跃 Cabazitaxel类抗多药耐药紫杉烷类抗肿瘤化合物及其制备方法
CN104817522A (zh) * 2015-04-01 2015-08-05 江苏红豆杉药业有限公司 一种7,10-二甲氧基-10DabⅢ的合成方法
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927118A (en) * 1973-12-21 1975-12-16 Crown Zellerbach Corp Process for monoetherification of polyhydric benzenes
EP0304244A3 (en) * 1987-08-18 1990-01-10 Takeda Chemical Industries, Ltd. Propanediol derivatives, their production and use
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
FR2696459B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
TW467896B (en) * 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
GB9405400D0 (en) * 1994-03-18 1994-05-04 Erba Carlo Spa Taxane derivatives
EP0757695A1 (en) * 1994-04-28 1997-02-12 Allelix Biopharmaceuticals Inc. Guanidino-substituted compounds
IT1274250B (it) * 1995-02-21 1997-07-15 Himont Inc Dieteri utilizzabili nella preparazione di catalizzatori ziegler-natta
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5688977A (en) * 1996-02-29 1997-11-18 Napro Biotherapeutics, Inc. Method for docetaxel synthesis

Also Published As

Publication number Publication date
EE200000155A (et) 2001-06-15
CA2304833A1 (fr) 1999-05-27
CZ20001789A3 (cs) 2000-11-15
FR2771092A1 (fr) 1999-05-21
PL191240B1 (pl) 2006-04-28
DZ2653A1 (fr) 2003-03-15
IL135512A (en) 2004-06-20
JP4359386B2 (ja) 2009-11-04
NO20002443L (no) 2000-05-11
BRPI9814658B8 (pt) 2021-05-25
CO4771105A1 (es) 1999-04-30
CZ292642B6 (cs) 2003-11-12
BR9814658A (pt) 2000-10-03
MXPA00002244A (es) 2002-04-24
CN100375744C (zh) 2008-03-19
AU755376B2 (en) 2002-12-12
CN1270586A (zh) 2000-10-18
EP1032565A1 (fr) 2000-09-06
MY121031A (en) 2005-12-30
DE69811530D1 (de) 2003-03-27
JP2001523673A (ja) 2001-11-27
SK7102000A3 (en) 2000-11-07
UY25256A1 (es) 2001-08-27
EP1032565B1 (fr) 2003-02-19
HUP0100519A1 (hu) 2001-06-28
PL340579A1 (en) 2001-02-12
TW518329B (en) 2003-01-21
AP2000001816A0 (en) 2000-06-30
EE04277B1 (et) 2004-04-15
OA11384A (fr) 2004-01-27
NZ504125A (en) 2002-10-25
BRPI9814658B1 (pt) 2016-07-19
TR200001415T2 (tr) 2001-01-22
ID24620A (id) 2000-07-27
AU1242299A (en) 1999-06-07
AP1198A (en) 2003-08-27
PT1032565E (pt) 2003-07-31
IL135512A0 (en) 2001-05-20
ZA9810511B (en) 1999-05-25
MA24817A1 (fr) 1999-12-31
HU228188B1 (en) 2013-01-28
SK283932B6 (sk) 2004-05-04
FR2771092B1 (fr) 1999-12-17
WO1999025704A1 (fr) 1999-05-27
IS5471A (is) 2000-04-26
IS2272B (is) 2007-07-15
TNSN98207A1 (fr) 2005-03-15
EA200000539A1 (ru) 2000-12-25
US5962705A (en) 1999-10-05
HUP0100519A3 (en) 2002-09-30
KR20010032138A (ko) 2001-04-16
GEP20022822B (en) 2002-10-25
NO325664B1 (no) 2008-07-07
IN191018B (bg) 2003-09-13
CA2304833C (fr) 2007-03-27
KR100581656B1 (ko) 2006-05-23
NO20002443D0 (no) 2000-05-11
AR017639A1 (es) 2001-09-12
ATE232855T1 (de) 2003-03-15
DE69811530T2 (de) 2003-10-02
UA56275C2 (uk) 2003-05-15
ES2192795T3 (es) 2003-10-16
BG64281B1 (bg) 2004-08-31
DK1032565T3 (da) 2003-06-02
SI1032565T1 (en) 2003-06-30
EA002622B1 (ru) 2002-06-27

Similar Documents

Publication Publication Date Title
BG104455A (bg) Метод за получаване на производни от класа на таксоидите
PL332541A1 (en) D-olanzapin dihydrate
DE69716135D1 (en) In 6-position durch thio substituierte paclitaxele
HU9402342D0 (en) Phosphono-oxymethyl-ethers of taxane derivatives
ZA983047B (en) An oleonsin 5' regulatory region for the modification of plant seed lipid composition
AP9400635A0 (en) 1,5 Benzodiaze pine derivatives
EP0727992A4 (en) 2'-AND / OR 7-SUBSTITUTED TAXOIDS
AU658296B2 (en) 7 beta-substituted-4-aza-5 alpha-cholestan-3-ones as 5 alpha-reductase inhibitors
EP0674643A4 (en) CUMARINE DERIVATIVES AS RETROVIRAL INHIBITORS.
HUP0004085A3 (en) Novel 3,6-hemiketals from the class of 9a-azalides
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
AP9400632A0 (en) Ether derivatives.
GB9405400D0 (en) Taxane derivatives
EP1011329A4 (en) PACLITAXELS 7-METHYLTHIOOXOMETHYLE AND 7-METHYLTHIODIOXOMETHYLE
GB2296239B (en) Taxane derivatives
ZA979927B (en) A phospholipidic composition method for the production of such a composition and its use
ZA954145B (en) Novel 1,1-bis(heteroazolyl) alkane derivatives and their use as neuroprotective agents
GR3019685T3 (en) Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
ES2162203T3 (es) Procedimiento de preparacion de 3-piperazinilbenzoisotiazoles.
EP1306366A3 (en) New dibenzosuberone derivatives
GB9825708D0 (en) Label or the like for lottery purchase incentive scheme
IT1283725B1 (it) Rotella di sicurezza, particolarmente studiata per componenti d'arredamento, o simili
AU1375P (en) FURANO NO. 18 Humulus lupulus
GB9724727D0 (en) Label or the like for lottery purchase incentive scheme
GB9619347D0 (en) The 'close' peg